Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 18, 2017 – The FDA approved an update to the Warnings and Precautions section of the Yondelis (trabectedin) drug label, regarding capillary leak syndrome (CLS).
Return to publications